INFECTIOUS DISEASES SOCIETY OF AMERICA

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (10)

date	from	type	amount	source
—	Jon Bouker	lobbied_for	—	lda_lobbyist_client
—	Starshine Chun	lobbied_for	—	lda_lobbyist_client
—	Blake Thelander	lobbied_for	—	lda_lobbyist_client
—	Oliver Spurgeon Iii	lobbied_for	—	lda_lobbyist_client
—	Byron Dorgan	lobbied_for	—	lda_lobbyist_client
—	Philip English	lobbied_for	—	lda_lobbyist_client
—	Dan Renberg	lobbied_for	—	lda_lobbyist_client
—	Brian Coen	lobbied_for	—	lda_lobbyist_client
—	Kelsey Griswold-Berger	lobbied_for	—	lda_lobbyist_client
2026-01-01	ARENTFOX SCHIFF LLP	lobbies_for	$50,000	lda_filing

Outbound (5)

date	type	to	amount	role	source
2026-01-01	lobbies_on_bill	HR 4445 — Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025	—	H.R. 4445	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 5304 — Departments of Labor, Health and Human Services, and Education, and Related Agencies Appro	—	H.R. 5304	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 7148 — Consolidated Appropriations Act, 2026	—	H.R.7148	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 7352 — PASTEUR Act of 2026	—	H.R.7352	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 2587 — Departments of Labor, Health and Human Services, and Education, and Related Agencies Approp	—	S. 2587	lobbying_bill_mention

Source id: 44996
General description: Medical association promoting public health and prevention of infectious diseases
State: VA
Country: US
Principal place of business: US
Effective date: 2022-01-21
Total spend (across 1 ingested filings): $50,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-17	`Q1`	2026	ARENTFOX SCHIFF LLP	$50,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page. Want to partner? Contact us.